Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants
- PMID: 9171346
- PMCID: PMC1169833
- DOI: 10.1093/emboj/16.9.2319
Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants
Abstract
The urokinase-type plasminogen activator (uPA) and the matrix-degrading metalloproteinases MMP-2 and MMP-9 (type IV collagenases/gelatinases) have been implicated in a variety of invasive processes, including tumor invasion, metastasis and angiogenesis. MMP-2 and MMP-9 are secreted in the form of inactive zymogens that are activated extracellularly, a fundamental process for the control of their activity. The physiological mechanism(s) of gelatinase activation are still poorly understood; their comprehension may provide tools to control cell invasion. The data reported in this paper show multiple roles of the uPA-plasmin system in the control of gelatinase activity: (i) both gelatinases are associated with the cell surface; binding of uPA and plasmin(ogen) to the cell surface results in gelatinase activation without the action of other metallo- or acid proteinases; (ii) inhibition of uPA or plasminogen binding to the cell surface blocks gelatinase activation; (iii) in soluble phase plasmin degrades both gelatinases; and (iv) gelatinase activation and degradation occur in a dose- and time-dependent manner in the presence of physiological plasminogen and uPA concentrations. Thus, the uPA-plasmin system may represent a physiological mechanism for the control of gelatinase activity.
Similar articles
-
Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.Thromb Haemost. 1998 Jun;79(6):1171-6. Thromb Haemost. 1998. PMID: 9657444
-
Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.J Cell Physiol. 1996 May;167(2):333-40. doi: 10.1002/(SICI)1097-4652(199605)167:2<333::AID-JCP18>3.0.CO;2-8. J Cell Physiol. 1996. PMID: 8613475
-
Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.J Pept Sci. 2000 Sep;6(9):432-9. doi: 10.1002/1099-1387(200009)6:9<432::AID-PSC279>3.0.CO;2-Q. J Pept Sci. 2000. PMID: 11016879
-
Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.Thromb Haemost. 1997 Jul;78(1):497-500. Thromb Haemost. 1997. PMID: 9198203 Review.
-
Mechanisms for pro matrix metalloproteinase activation.APMIS. 1999 Jan;107(1):38-44. doi: 10.1111/j.1699-0463.1999.tb01524.x. APMIS. 1999. PMID: 10190278 Review.
Cited by
-
Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation.J Biol Chem. 2012 Jun 29;287(27):22643-53. doi: 10.1074/jbc.M111.337949. Epub 2012 May 10. J Biol Chem. 2012. PMID: 22577146 Free PMC article.
-
PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor.Neoplasia. 2007 Nov;9(11):927-37. doi: 10.1593/neo.07544. Neoplasia. 2007. PMID: 18030361 Free PMC article.
-
Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.Inflammation. 1998 Dec;22(6):599-617. doi: 10.1023/a:1022314530777. Inflammation. 1998. PMID: 9824774
-
Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line.Clin Exp Metastasis. 1998 Aug;16(6):489-500. doi: 10.1023/a:1006550503612. Clin Exp Metastasis. 1998. PMID: 9872597
-
Implications of MMP-12 in the pathophysiology of ischaemic stroke.Stroke Vasc Neurol. 2024 Apr 30;9(2):97-107. doi: 10.1136/svn-2023-002363. Stroke Vasc Neurol. 2024. PMID: 37336584 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous